Total raised
$2.5M
Last: Series A 2023-02
Stage
Series A
Founded
2017
Headcount
10
HQ
Nir Am
Sector
Health Tech & Life Sciences
About
Inretio develops solutions that address complications during clot retrieval procedures for ischemic stroke treatment.
Funding history · 1 round · $2.5M total
2023-02
Series A
$2.5M
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Inretio's primary focus?
- Inretio develops solutions to address complications that arise during clot retrieval procedures for ischemic stroke treatment.
- When was Inretio founded?
- Inretio was founded in December 2017.
- Where is Inretio headquartered?
- Inretio is headquartered in Nir Am, South District, Israel.
- What is Inretio's current funding stage?
- Inretio is currently in the Series A funding stage.
- When did Inretio complete its last funding round and how much was raised?
- In February 2023, Inretio completed a Series A round, raising $2,500,000.
- Which investor participated in Inretio's Series A funding round?
- Therma Bright was an investor in Inretio's Series A funding round in February 2023.
- What is the estimated employee count for Inretio?
- Inretio has an estimated employee count of 1-10 people.
- Who is a founder of Inretio?
- Raviv Vine is a founder of Inretio.
- What sector does Inretio primarily operate in?
- Inretio primarily operates in the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Tags
treatmentsmedical-devicesstroke